Cross-reactive, natural IgG recognizing L. major promote parasite internalization by dendritic cells and promote protective immunity.
B cell
Dendritic cell
Leishmania major
Natural IgG
Journal
Journal of molecular medicine (Berlin, Germany)
ISSN: 1432-1440
Titre abrégé: J Mol Med (Berl)
Pays: Germany
ID NLM: 9504370
Informations de publication
Date de publication:
03 2022
03 2022
Historique:
received:
12
08
2021
accepted:
07
09
2021
revised:
04
09
2021
pubmed:
5
10
2021
medline:
5
4
2022
entrez:
4
10
2021
Statut:
ppublish
Résumé
In cutaneous leishmaniasis, infection of dendritic cells (DC) is essential for generation of T cell-dependent protective immunity. DC acquires Leishmania major through Fc receptor (FcR)-mediated uptake of complexes comprising antibodies bound to parasites. We now assessed the development of the initial B cell and DC response to the parasite itself and if natural IgG play a role. L. major parasites display large numbers of phospholipids on their surface. Parasites were opsonized with normal mouse serum (NMS), or serum containing anti-phospholipid IgG (PL). We found that L. major bound to PL which significantly enhanced parasite phagocytosis by DC as compared to NMS. Similar results were obtained with cross-reactive human PL antibodies using myeloid primary human DC. In addition, mice infected with PL-opsonized parasites showed significantly improved disease outcome compared to mice infected with NMS-opsonized parasites. Finally, IgMi mice, which produce membrane-bound IgM only and no secreted antibodies, displayed increased susceptibility to infection as compared to wild types. Interestingly, once NMS was administered to IgMi mice, their phenotype was normalized to that of wild types. Upon incubation with IgG-opsonized parasite (IgG derived from infected mice or using PL antibodies), also the IgMi mice were able to show superior immunity. Our findings suggest that "natural" cross-reactive antibodies (e.g., anti-PL Ab) in NMS bind to pathogens to facilitate phagocytosis, which leads to induction of protective immunity via preferential DC infection. Prior L. major-specific B cell-priming does not seem to be absolutely required to facilitate clearance of this important human pathogen in vivo. KEY MESSAGES: We found that anti-phospholipid (anti-PL) antibodies enhance phagocytosis of L. major by DCs. We also found that normal mouse sera have natural antibodies that can imitate PL specific antibodies. Using different genetically modified mice, we found that these antibodies can be IgG, not only IgM.
Identifiants
pubmed: 34604942
doi: 10.1007/s00109-021-02137-4
pii: 10.1007/s00109-021-02137-4
pmc: PMC8844169
doi:
Substances chimiques
Immunoglobulin G
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
451-460Commentaires et corrections
Type : ErratumIn
Informations de copyright
© 2021. The Author(s).
Références
Front Cell Infect Microbiol. 2012 Jul 12;2:96
pubmed: 22912937
Int J Med Microbiol. 2018 Jan;308(1):206-214
pubmed: 29129568
EMBO J. 2013 Nov 13;32(22):2905-19
pubmed: 24002211
Cell Mol Life Sci. 2010 May;67(10):1653-9
pubmed: 20140747
PLoS One. 2013 Apr 02;8(4):e60726
pubmed: 23589757
Front Immunol. 2021 Mar 11;12:620144
pubmed: 33776999
Cell Commun Signal. 2020 Jan 15;18(1):10
pubmed: 31941500
Nature. 1988 Apr 21;332(6166):738-40
pubmed: 3258649
J Exp Med. 2003 Jul 21;198(2):191-9
pubmed: 12860932
Nat Rev Immunol. 2002 Nov;2(11):845-58
pubmed: 12415308
J Exp Med. 2006 Jan 23;203(1):177-88
pubmed: 16418399
Blood Rev. 2020 Jan;39:100610
pubmed: 31471128
Med Microbiol Immunol. 2008 Jun;197(2):145-9
pubmed: 18330599
Eur J Immunol. 2000 Sep;30(9):2729-40
pubmed: 11009109
J Exp Med. 1999 Jan 4;189(1):25-35
pubmed: 9874561
J Exp Med. 2001 Nov 19;194(10):1497-506
pubmed: 11714756
Trends Immunol. 2009 Jan;30(1):43-51
pubmed: 19058756
EMBO J. 2013 Nov 13;32(22):2897-9
pubmed: 24162726
J Immunol. 2015 Jan 1;194(1):13-20
pubmed: 25527792
J Immunol. 2006 Nov 1;177(9):6504-16
pubmed: 17056583
Lancet. 2018 Sep 15;392(10151):951-970
pubmed: 30126638
J Exp Med. 2007 Apr 16;204(4):747-58
pubmed: 17420268